A Multi-center Clinical Longitudinal Study of Neuropathic Pain by Collecting Data
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: A multi-center clinical longitudinal study of neuropathic pain by collecting data on patients' brain physiology and cognitive function.
- Who it may be relevant to
- Registry conditions: Pain. Basic parameters: 18 years — 85 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Multi-center Clinical Longitudinal Study of Neuropathic Pain by Collecting Data on Patients' Brain Physiology and Cognitive Function
Overview
A multi-center clinical longitudinal study of neuropathic pain by collecting data on patients' brain physiology and cognitive function
Detailed description
Using the use of pain visual analog scale (VAS), digital pain grading method (NRS), neuropathic pain assessment scale (DN4), sleep quality (Pittsburgh sleep quality index, Ascens insomnia scale), social support assessment scale (SSQ), Montreal cognitive assessment scale (MoCA), Barrett impulse scale (BIS), anxiety and depression score (GAD-7, PHQ-9), emotional tasks, cognitive function (N-back, time perception, delay-discount), electroencephalogram (EEG), near-infrared brain function imaging (fNIRS) and other indicators to study the dynamic changes of various factors in the process of acute pain.
Interventions
- Device A multi-center clinical longitudinal study of neuropathic pain by collecting data on patients' brain physiology and cognitive function
Using the use of pain visual analog scale (VAS), digital pain grading method (NRS), neuropathic pain assessment scale (DN4), sleep quality (Pittsburgh sleep quality index, Ascens insomnia scale), social support assessment scale (SSQ), Montreal cognitive assessment scale (MoCA), Barrett impulse scale (BIS), anxiety and depression score (GAD-7, PHQ-9), emotional tasks, cognitive function (N-back, time perception, delay-discount), electroencephalogram (EEG), near-infrared brain function imaging (fN
Primary outcome measures
- Visual Analogue Scale/Score（VAS） [Time frame: 1 month]
- digital pain grading method (NRS) [Time frame: 1 month]
- neuropathic pain assessment scale (DN4) [Time frame: 1 month]
- sleep quality (Pittsburgh sleep quality index, Ascens insomnia scale) [Time frame: 1 month]
- EEG [Time frame: 1 month]
- Barrett impulse scale (BIS) [Time frame: 1 month]
- (Generalized Anxiety Disorder,GAD-7) [Time frame: 1 month]
- (Patient Health Questionnaire-9 [Time frame: 1 month]
Secondary outcome measures (2)
- Montreal cognitive assessment scale (MoCA) [Time frame: 1 month]
- ocial support assessment scale (SSQ) [Time frame: 1 month]
Eligibility criteria
Inclusion criteria
- The subjects voluntarily participated in the study and signed an informed consent form;
- The age is between 18 years old (inclusive) and 85 years old (inclusive), regardless of gender;
- Body mass index (BMI) ≤ 45;
- Clinically clearly diagnosed neuropathological pain (pain VAS score ≥4 or above);
- Did not participate in the drug/medical device test within 3 months before the test;
Exclusion criteria
\-
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
China · 1 center
- Ke Ma — Shanghai
Identifiers
NCT: NCT06290024 · XH-23-013